Literature DB >> 2928922

A critique of posterior lumbar interbody fusion: 12 years' experience with 250 patients.

B L Rish1.   

Abstract

A comprehensive long-term follow-up analysis of the clinical and radiographic results of posterior lumbar interbody fusion for lumbar disk disease is presented. This 12-year experience with 250 patients is compared with a previous critique of our surgical management of lumbar disk disease by laminotomy and diskectomy alone. The clinical results and complications rates are comparable. However, posterior lumbar interbody fusion significantly reduces the rate of recurrent problems requiring subsequent surgery. Careful technique and judgment are mandatory for success with posterior lumbar interbody fusion. Homologous tissue bank bone grafts were found to be as successful as autogenous bone. Posterior lumbar interbody fusion represents an improvement in the surgical management of lumbar disk disease.

Entities:  

Mesh:

Year:  1989        PMID: 2928922     DOI: 10.1016/0090-3019(89)90053-0

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  Kluger's "fixateur interne" for spinal instability.

Authors:  G Sandvoss; H Feldmann
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

2.  Evaluation of the 96/4 PLDLLA polymer resorbable lumbar interbody cage in a long term animal model.

Authors:  Jean Y Lazennec; Abdallah Madi; Marc A Rousseau; Bernard Roger; Gérard Saillant
Journal:  Eur Spine J       Date:  2006-05-31       Impact factor: 3.134

3.  Fusion rate after posterior lumbar interbody fusion with carbon fiber implant: 1-year follow-up of 51 patients.

Authors:  T Tullberg; B Brandt; J Rydberg; P Fritzell
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

4.  The memory metal minimal access cage: a new concept in lumbar interbody fusion-a prospective, noncomparative study to evaluate the safety and performance.

Authors:  D Kok; R D Donk; F H Wapstra; A G Veldhuizen
Journal:  Adv Orthop       Date:  2012-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.